Discovery and Validation of Circulating microRNAs as Biomarkers for Epileptogenesis after Experimental Traumatic Brain Injury–The EPITARGET Cohort
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24032823 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Mette Heiskanen und 9 weiteren Autor:innen. Beteiligte Einrichtung: A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 70211 Kuopio, Finland. Hauptthemen laut MEDLINE: Circulating MicroRNA, Brain Injuries, Traumatic, Brain Injuries, MicroRNAs. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Academy of Finland, Sigrid Jusélius Foundation, European Union's Seventh Framework Programme (FP7/2007-2013).
Abstract (Originalsprache)
Traumatic brain injury (TBI) causes 10–20% of structural epilepsies and 5% of all epilepsies. The lack of prognostic biomarkers for post-traumatic epilepsy (PTE) is a major obstacle to the development of anti-epileptogenic treatments. Previous studies revealed TBI-induced alterations in blood microRNA (miRNA) levels, and patients with epilepsy exhibit dysregulation of blood miRNAs. We hypothesized that acutely altered plasma miRNAs could serve as prognostic biomarkers for brain damage severity and the development of PTE. To investigate this, epileptogenesis was induced in adult male Sprague Dawley rats by lateral fluid-percussion-induced TBI. Epilepsy was defined as the occurrence of at least one unprovoked seizure during continuous 1-month video-electroencephalography monitoring in the sixth post-TBI month. Cortical pathology was analyzed by magnetic resonance imaging on day 2 (D2), D7, and D21, and by histology 6 months post-TBI. Small RNA sequencing was performed from tail-vein plasma samples on D2 and D9 after TBI (n = 16, 7 with and 9 without epilepsy) or sham operation (n = 4). The most promising miRNA biomarker candidates were validated by droplet digital polymerase chain reaction in a validation cohort of 115 rats (8 naïve, 17 sham, and 90 TBI rats [21 with epilepsy]). These included 7 brain-enriched plasma miRNAs (miR-434-3p, miR-9a-3p, miR-136-3p, miR-323-3p, miR-124-3p, miR-212-3p, and miR-132-3p) that were upregulated on D2 post-TBI (p < 0.001 for all compared with naïve rats). The acute post-TBI plasma miRNA profile did not predict the subsequent development of PTE or PTE severity. Plasma miRNA levels, however, predicted the cortical pathology severity on D2 (Spearman ρ = 0.345–0.582, p < 0.001), D9 (ρ = 0.287–0.522, p < 0.001–0.01), D21 (ρ = 0.269–0.581, p < 0.001–0.05) and at 6 months post-TBI (ρ = 0.230–0.433, p < 0.001–0.05). We found that the levels of 6 of 7 miRNAs also reflected mild brain injury caused by the craniotomy during sham operation (ROC AUC 0.76–0.96, p < 0.001–0.05). In conclusion, our findings revealed that increased levels of neuronally enriched miRNAs in the blood circulation after TBI reflect the extent of cortical injury in the brain but do not predict PTE development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 70211 Kuopio, Finland.
- Department of (Neuro)Pathology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
- Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.
- Chalfont Centre for Epilepsy, Buckinghamshire SL9 0RJ, UK.
- Swammerdam Institute for Life Sciences, Center for Neuroscience, University of Amsterdam, 1098 XH Amsterdam, The Netherlands.
- Stichting Epilepsie Instellingen Nederland, 2103 SW Heemstede, The Netherlands.
ORCID-Profile: Mette Heiskanen, Erwin A van Vliet, Eppu Manninen, Pedro Andrade, Eleonora Aronica, Asla Pitkänen
Förderung
- Academy of Finland
- Sigrid Jusélius Foundation
- European Union's Seventh Framework Programme (FP7/2007-2013)
- Sigrid Jusélius Foundation, and the European Union’s Seventh Framework Programme (FP7/2007-2013)
Zitieren
APA
Heiskanen, M., Das Gupta, S., Mills, J. D., van Vliet, E. A., Manninen, E., Ciszek, R., Andrade, P., Puhakka, N., Aronica, E., & Pitkänen, A. (2023). Discovery and Validation of Circulating microRNAs as Biomarkers for Epileptogenesis after Experimental Traumatic Brain Injury–The EPITARGET Cohort. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032823
Vancouver
Heiskanen M, Das Gupta S, Mills JD, van Vliet EA, Manninen E, Ciszek R, et al. Discovery and Validation of Circulating microRNAs as Biomarkers for Epileptogenesis after Experimental Traumatic Brain Injury–The EPITARGET Cohort. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032823
BibTeX
@article{Heiskanen2023,
author = {Heiskanen, Mette and Das Gupta, Shalini and Mills, James D and van Vliet, Erwin A and Manninen, Eppu and Ciszek, Robert and Andrade, Pedro and Puhakka, Noora and Aronica, Eleonora and Pitkänen, Asla},
title = {Discovery and Validation of Circulating microRNAs as Biomarkers for Epileptogenesis after Experimental Traumatic Brain Injury–The EPITARGET Cohort},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24032823}
}
EUVIMED